Adjust expands advisory proposition with acquisition of Accent Advies
Amsterdam, December 22nd 2025 – Our portfolio company Adjust Consulting (Adjust) is expanding its advisory proposition with the acquisition of Accent Advies. This transaction strengthens Adjust’s position in control, risk management and audit, and further reinforces its presence in the semi-public sector and the housing corporation sector.
Guido Winnink, CEO of Adjust: “The acquisition of Accent Advies is a valuable addition to our service offering in a domain and sector where we already have a strong position. The expertise, experience and capabilities of Accent Advies will enable us to support our clients even better in addressing complex challenges in control, risk management and audit.”
Marc Breij, on behalf of Accent Advies: “By joining Adjust, we can offer our clients a broader and more comprehensive range of services. At the same time, we become part of a growing organization, allowing us to further strengthen our organization together, for the benefit of our clients and our own development.”
Since becoming a shareholder in 2024, Holland Capital has actively supported Adjust in its operational and strategic development. The collaboration with Accent Advies aligns with Adjust’s buy-and-build strategy.
About Accent Advies
Accent Advies is a specialized advisory firm focusing on integrated risk management, governance, internal audit, process optimization, and strengthening organizational and governance models. The firm is led by Marc Breij, Frank van Egeraat and Sander Boelen, and works with a team of associates.
About Adjust
Founded in 2003, Adjust is a leading advisory firm in the Netherlands specializing in procurement and contract management. At Adjust, people and clients come first: consultants work with passion, integrity and dedication, always striving to balance commercial success with societal impact. Adjust has won the FD Gazellen Award ten times and has been included in the Top 250 Growth Companies by the Erasmus Centre for Entrepreneurship for two consecutive years.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Benelux and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare and Technology sectors. They understand the dynamics and opportunities and have an extensive network in these sectors.
Yenlo and Fides join forces
Amsterdam, 21 September 2020 – Our portfolio company Yenlo (the integration specialist in the field of API and ESB technology) and Fides (the AFAS migration and integration partner for healthcare and education) join forces to support the integration for customers with...
Holland Capital invests in innovative primary care IT platform HealthConnected
Amsterdam/Alkmaar, September 1st, 2020 – Holland Capital, a Dutch based investment firm, invests in HealthConnected, a healthcare IT platform for the primary care market. This investment enables HealthConnected to focus on the expansion to new regions in the...
Holland Capital investeert in innovatief eerstelijns IT-zorgplatform HealthConnected
Amsterdam/Alkmaar, 1 september 2020 - Participatiemaatschappij Holland Capital investeert in HealthConnected, een IT-zorgplatform voor eerstelijnszorg. Met de investering richt HealthConnected zich op de uitrol naar nieuwe regio’s in Nederland en de verdere...
Sirius Medical haalt EUR 4,4 miljoen op om Sirius Pintuition te lanceren
Sirius Medical haalt EUR 4,4 miljoen op om Sirius Pintuition te lancerenEen innovatieve borstkanker lokalisatie technologie Amsterdam, 14 juli 2020 – Participatiemaatschappij Holland Capital investeert samen met BOM Brabant Ventures en Curie Capital 4,4 miljoen euro...
Sirius Medical raises €4.4M to launch Sirius Pintuition
Sirius Medical raises €4.4M to launch Sirius PintuitionAn innovative breast cancer localization technology Amsterdam, July 14th, 2020 – Investment company Holland Capital invests 4.4 million euros in Sirius Medical together with BOM Brabant Ventures and Curie Capital....
Investeren in Coronatijd: Hubert Verbeek aan het woord
Interview met Hubert Verbeek door Jos Schelfhout van Navigator Network Executive Search. Originele bron. Hubert Verbeek: ‘best practices’ helpt de bedrijven in ons portfolio Een rondje langs investeerders. Met hen bespreken we de huidige ‘Corona-tijd’; hoe kijken zij...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl